Exclusive Innovation Validated After Three Years of Investment and Patented IP Development, Proven Against Major Infectious Bacteria, Viruses (Including Covid-19) and Mold, as Well as Candida Auris
NEW YORK, NY, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Applied UV, Inc. (NASDAQ: AUVI), a pioneering force in Smart Buildings Technologies, is pleased to announce a significant accomplishment through its Sterilumen subsidiary: the Company's first purchase order for its disinfecting mirrors has recently been received. This order is for the renowned Mt. Sinai Hospital in New York. This significant milestone represents the successful culmination of three years of research, investment, and intellectual property (IP) development by Applied UV. Our patented UV disinfecting mirrors focus on typical sinks and adjacent areas.
These groundbreaking disinfecting mirrors have been rigorously laboratory tested and shown to be effective against Candida auris, a crucial achievement in light of increasing global concerns over resistant pathogens (https://www.nbcnews.com/health/health-news/cdc-fungal-infection-candida-auris-alarming-spread-rcna75477)
In a recent podcast featured on the American Society. for Microbiology (https://asm.org/Podcasts/MTM/Episodes/Antibiotic-Resistant-Infections-in-Hospital-Sinks),
Amy Mathers, M.D., D(ABMM), associate professor of medicine and pathology at the University of Virginia, Charlottesville, studied how drug-resistant bacteria can reside in hospital sinks. The bacteria, existing in a biofilm in the pipe right below the drain, can be transferred in droplets when the water is run. These droplets can fall as far as 36 inches from the drain plate and can contaminate the sink bowl or patient care items next to the sink.
Sinks and drains are one of the most dangerous areas where infection, bacteria, mold and pathogens accumulate. Manual, standard cleaning methods are ineffective as a disinfectant. Additionally, our laboratory validated Lumicide™ patented UVC technology is the only solution that continuously and thoroughly eliminates bacteria in and around hand hygiene sinks in hospitals, healthcare and heavily trafficked public areas.
Our various hospital partnerships underscore the trust and credibility we have built in the market," said Max Munn, CEO of Applied UV. "Today's announcement is a testament to our commitment to innovation, safety, and efficacy. We have always believed in the potential of our disinfecting mirrors, and the multiple laboratory validations exemplifies our unwavering dedication to advancing technology for the greater good."
Munn added, "As we continue to evolve, our primary focus remains on how our technologies can enhance safety, elevate experiences, and make a genuine positive impact."
Prominent names like University of Chicago Medical, Mass General, and Mercy Children’s Hospital are among Applied UV's clientele. Collaborations with such notable industry leaders solidify the company's reputation as a trusted solution provider in the realm of smart building technology.
For more on the latest developments and other exciting news, follow us on Twitter.
About Applied UV
Applied UV, Inc. engages in the pursuit of technologies focused on global food security, air quality, and specialty building solutions tailored for the commercial and hospitality sectors. More details about Applied UV, Inc., and its subsidiaries can be found at https://www.applieduvinc.com.
Forward-Looking Statements
The information contained herein may contain “forward‐looking statements.” Forward‐looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
For additional Company Information:
Applied UV Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
